So a monovalent booster should not wane in effectiveness as the bivalent?
this post was submitted on 18 Jun 2023
25 points (100.0% liked)
World News
22025 readers
81 users here now
Breaking news from around the world.
News that is American but has an international facet may also be posted here.
Guidelines for submissions:
- Where possible, post the original source of information.
- If there is a paywall, you can use alternative sources or provide an archive.today, 12ft.io, etc. link in the body.
- Do not editorialize titles. Preserve the original title when possible; edits for clarity are fine.
- Do not post ragebait or shock stories. These will be removed.
- Do not post tabloid or blogspam stories. These will be removed.
- Social media should be a source of last resort.
These guidelines will be enforced on a know-it-when-I-see-it basis.
For US News, see the US News community.
This community's icon was made by Aaron Schneider, under the CC-BY-NC-SA 4.0 license.
founded 2 years ago
MODERATORS
I think it's just that the bivalent booster was targeting (a) an extinct variant and (b) a different Omicron subvariant. This will target some form of Omicron XBB, I think, which has been the dominant strain for months now.
I remember the very first Covid shot making it feel as though my arm was kicked by Chuck Norris. Super sore. The boosters weren't so bad. I'll get another jab if it means not catching Covid or just having mild symptoms.
Can't wait to be able to get mine in a year or two!